A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus

Clinical trial NCT07465224 · RECRUITING

Trial details

NCT number: NCT07465224
Sponsor: Alnylam Pharmaceuticals
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)

Start date: 2026-01-15
Primary completion: 2027-05-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.